about
Distinguishing adult-onset asthma from COPD: a review and a new approach.Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease.Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophiliaAirway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy.Fungus-associated asthma: overcoming challenges in diagnosis and treatment.Diagnosis and investigation in the severe asthma clinic.Severe asthma: Current management, targeted therapies and future directions-A roundtable report.Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.Plasminogen activator inhibitor-1 in sputum and nasal lavage fluids increases in asthmatic patients during common colds.Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix.Multidimensional assessment of severe asthma: A systematic review and meta-analysis.Late-onset asthma: current perspectives.Impact of Schizophyllum sensitization on decline of lung function in asthma.Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma.Full blood count parameters for the detection of asthma inflammatory phenotypes.Identifying Asthma Exacerbation-Related Emergency Department Visit Using Electronic Medical Record and Claims Data
P2860
Q34198033-9A5DBEC7-DFD2-4489-840C-B8DB18F34AA3Q35175185-68017E0F-1395-4C31-8837-9813C8A1EDB4Q35329384-4A83EDE7-B278-453D-BE7D-5052D7A7F551Q37641498-3CA4B8F7-BFDD-42F6-8E73-A3065C37954EQ38151900-900BAA4C-2A8D-452E-8600-F19BB9CBE1FDQ38192062-D2F95681-AAD5-4B4E-AD2A-D70B2E10E7D0Q38770013-A5C1231F-C109-43D9-A043-66927EB1E026Q38788721-240E594B-F59B-404A-A879-203684BB1F5CQ38790815-958E3C23-C360-4045-945E-822BC1A3768CQ39650450-88590B14-59E6-44F0-B0FE-ECD5BC8F5F76Q42286365-B9B27FC1-FF7D-44B5-B66F-81972B2096C5Q42546297-98751AC0-5598-4079-A46B-7952447A0221Q47123466-7836C872-6FA6-41FE-ADB6-E8DD708FD3EDQ47701122-3EC1BDCA-7288-4ADD-BEC4-FCCF9ED89D45Q49296781-68BEA05F-9B68-42EC-9926-29477CE68308Q51238660-64E88930-B5B6-40E6-817E-C5F0C20C6202Q51684183-7C3BBEAE-D0B0-4AF1-AD58-1BEB5EFC5BB9Q51722268-EC24EB73-21A4-4BC4-BF97-5D1E55A7A4DBQ56889957-56B2B305-BFCC-4B24-89A7-F2F9BC66E88E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Exacerbations of severe asthma.
@en
type
label
Exacerbations of severe asthma.
@en
prefLabel
Exacerbations of severe asthma.
@en
P2860
P1476
Exacerbations of severe asthma.
@en
P2093
P G Gibson
V M McDonald
P2860
P304
P356
10.1111/J.1365-2222.2012.03981.X
P577
2012-05-01T00:00:00Z